{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:14:37Z","timestamp":1792181677919,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.virusres.2013.12.020","type":"journal-article","created":{"date-parts":[[2013,12,24]],"date-time":"2013-12-24T13:30:21Z","timestamp":1387891821000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["DNA vaccines for HFRS: Laboratory and clinical studies"],"prefix":"10.1016","volume":"187","author":[{"given":"Connie S.","family":"Schmaljohn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin W.","family":"Spik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay W.","family":"Hooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Pt 3","key":"10.1016\/j.virusres.2013.12.020_bib0005","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1099\/0022-1317-70-3-615","article-title":"Characterization of Hantaan virus envelope glycoprotein antigenic determinants defined by monoclonal antibodies","volume":"70","author":"Arikawa","year":"1989","journal-title":"The Journal of General Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0010","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/j.vaccine.2012.01.024","article-title":"A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome","volume":"30","author":"Boudreau","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.12.020_bib0015","doi-asserted-by":"crossref","first-page":"e35996","DOI":"10.1371\/journal.pone.0035996","article-title":"DNA vaccine-generated duck polyclonal antibodies as a postexposure prophylactic to prevent hantavirus pulmonary syndrome (HPS)","volume":"7","author":"Brocato","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2013.12.020_bib0020","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1006\/viro.1994.1022","article-title":"Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae","volume":"198","author":"Chu","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0025","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1128\/JVI.77.18.9894-9905.2003","article-title":"Active and passive vaccination against hantavirus pulmonary syndrome with Andes virus M genome segment-based DNA vaccine","volume":"77","author":"Custer","year":"2003","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00030-11","article-title":"A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates","volume":"18","author":"Dupuy","year":"2011","journal-title":"Clinical and Vaccine Immunology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0035","doi-asserted-by":"crossref","first-page":"7345","DOI":"10.1016\/j.vaccine.2010.09.005","article-title":"Immunogenicity and protective efficacy of a DNA vaccine against Venezuelan equine encephalitis virus aerosol challenge in nonhuman primates","volume":"28","author":"Dupuy","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.12.020_bib0040","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1128\/JCM.35.5.1122-1130.1997","article-title":"Serological diagnosis of hantavirus infections by an enzyme-linked immunosorbent assay based on detection of immunoglobulin G and M responses to recombinant nucleocapsid proteins of five viral serotypes","volume":"35","author":"Elgh","year":"1997","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0045","first-page":"8","article-title":"A multiagent filovirus DNA vaccine delivered by intramuscular electroporation completely protects mice from ebola and Marburg virus challenge","author":"Grant-Klein","year":"2012","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"10.1016\/j.virusres.2013.12.020_bib2222","doi-asserted-by":"crossref","unstructured":"Hooper, J.W., Moon, J.E., Paolino, K.M., Newcomer, R., McLain, D.E., Josleyn, M., Hannaman, D., Schmaljohn, C., A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome delivered by intramuscular electroporation, C. CMI, in press.","DOI":"10.1111\/1469-0691.12553"},{"key":"10.1016\/j.virusres.2013.12.020_bib0050","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1128\/JVI.75.18.8469-8477.2001","article-title":"DNA vaccination with the Hantaan virus M gene protects Hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in Rhesus monkeys","volume":"75","author":"Hooper","year":"2001","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1006\/viro.1996.0113","article-title":"Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus","volume":"217","author":"Liang","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0060","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/viro.1997.8695","article-title":"Baculovirus expression of a human G2-specific, neutralizing IgG monoclonal antibody to Puumala virus","volume":"235","author":"Liang","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0065","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/14712598.7.11.1647","article-title":"Electroporation-based DNA immunisation: translation to the clinic","volume":"7","author":"Luxembourg","year":"2007","journal-title":"Expert Opinion on Biological Therapy"},{"key":"10.1016\/j.virusres.2013.12.020_bib0070","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/(SICI)1096-9071(200001)60:1<77::AID-JMV13>3.0.CO;2-S","article-title":"Clinical evaluation of a vaccinia-vectored Hantaan virus vaccine","volume":"60","author":"McClain","year":"2000","journal-title":"Journal of Medical Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0075","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.12.020_bib0080","doi-asserted-by":"crossref","first-page":"9563","DOI":"10.1128\/JVI.71.12.9563-9569.1997","article-title":"Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge","volume":"71","author":"Schmaljohn","year":"1997","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0085","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1128\/JVI.64.7.3162-3170.1990","article-title":"Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants","volume":"64","author":"Schmaljohn","year":"1990","journal-title":"Journal of Virology"},{"key":"10.1016\/j.virusres.2013.12.020_bib0090","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.2858126","article-title":"Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome","volume":"227","author":"Schmaljohn","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.virusres.2013.12.020_bib0095","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.1016\/j.vaccine.2008.03.097","article-title":"Mixing of M segment DNA vaccines to Hantaan virus and Puumala virus reduces their immunogenicity in hamsters","volume":"26","author":"Spik","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.virusres.2013.12.020_bib0100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0168-1702(93)90019-J","article-title":"Nucleotide and deduced amino acid sequences of the M and S genome segments of two Puumala virus isolates from Russia","volume":"30","author":"Xiao","year":"1993","journal-title":"Virus Research"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170213004498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170213004498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T17:22:36Z","timestamp":1597252956000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170213004498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":21,"alternative-id":["S0168170213004498"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2013.12.020","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA vaccines for HFRS: Laboratory and clinical studies","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2013.12.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}